Supplemental material
Modern Rheumatology
Volume 29, 2019 - Issue 5
Open access
2,992
Views
8
CrossRef citations to date
0
Altmetric
Original Article
Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study
Atsushi OgataDepartment of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Osaka, Japan; ;Division of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan; Correspondence[email protected]
http://orcid.org/0000-0003-3944-3442View further author information
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan; View further author information
, Tomonori IshiiDepartment of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan; View further author information
, Motohide KanekoKaneko Internal Medicine Rheumatology Clinic, Kawaguchi, Japan; View further author information
, Hiroko MiwaChugai Pharmaceutical Co., Ltd, Tokyo, JapanView further author information
, Shino OhsawaChugai Pharmaceutical Co., Ltd, Tokyo, JapanView further author information
, Reiji YamakawaChugai Pharmaceutical Co., Ltd, Tokyo, JapanView further author information
& the SHINOBI Study Group show all
Pages 767-774
|
Received 21 Jun 2018, Accepted 04 Oct 2018, Published online: 14 Dec 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.